From: The expanding spectrum of rare monogenic autoinflammatory diseases
Year of gene discovery | Disease* | N patients** | M/F ratio | Ethnicity*** | Ref | Mode of inheritance | Gene**** | Chromosome location | Most frequent mutation | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2008 | H Syndrome | Histiocytosis lymphadenopathy plus syndrome | 4 | 2/2 | 1 Indian case | 12 | Recessive | SLC29A3 | Solute Carrier Family | 10q22.1 | ND |
1 Pakistani case | 13 | ||||||||||
1 Morocan case | 10 | 29 (Nucleoside Transporter), Member 3 | |||||||||
1 Tunisian case | 11 | ||||||||||
2008 | NAPS12 | NLRP12 Associated Periodic Syndrome | 19 | 13/6 | 2 Guadeloupean families | 18 | Dominant | NLRP12 | NLR pyrin domain containing protein 12 | 19q43.42 | c.1054C>T, p.Arg352Cys |
17 | |||||||||||
1 Italian family | 58 | ||||||||||
6 Eastern-European cases | 16 | ||||||||||
1 Armenian case | 16 | ||||||||||
1 Italian case | 9 | ||||||||||
1 Guadeloupean case | 9 | ||||||||||
1 Irish case | |||||||||||
2009 | DIRA | Deficiency of Interleukin 1 Receptor Antagonist | 17 | 9/8 | 1 Turkish family | 23 | Recessive | IL1RN | Interleukin 1 | 2q13 | c.-64_1696del, p.IL1F9_IL1RNdel |
1 Lebanese | 22 | receptor antagonist | |||||||||
family | 22 | ||||||||||
2 Dutch families | 22 | c.213_227del, p.Asp72_Ile76del | |||||||||
1 Dutch case | 22 | ||||||||||
1 Canadian case | 22,27 | ||||||||||
2 Puerto-Rican cases | 25 | ||||||||||
2 Brazilian cases | 24,26 | ||||||||||
2 Unknown | |||||||||||
3 Dutch, | |||||||||||
1 Lebanese, | |||||||||||
1 Turkish, | |||||||||||
1 from unknown ancestry | |||||||||||
2011 | DITRA | Deficiency of Interleukin | 66 | 26/37 | 3 Tunisian families | 30 | Recessive | IL36RN | Interleukin 36 receptor antagonist | 2q13 | c.80C>T, p.Leu27Pro |
1 Algerian family | 9 | ||||||||||
36 Receptor Antagonist | 19 European cases | 32,35,37 | c.338C>T, p.Ser113Leu | ||||||||
10 Asian cases | 35 | c.28C>T, p.Arg10* | |||||||||
6 Tunisian cases | 30 | ||||||||||
6 German cases | 36 | ||||||||||
3 Japanese cases | 33,34 | ||||||||||
1 Spanish case | 9 | ||||||||||
1 Turkish case | 36 | ||||||||||
1 Iraqi case | 36 | ||||||||||
1 Russian case | 37 | ||||||||||
2012 | PSORS2 | Psoriasis susceptibility 2 | 45 | 24/21 | 1 European family | 42 | Dominant | CARD14 | Caspase recruitment domain-containing protein 14 | 17q25.3 | c.349G>A, p.Gly117Ser |
1 Taiwanese family | 42 | ||||||||||
1 Tunisian family | 43 | ||||||||||
3 German cases | 36 | ||||||||||
PRP | Pityriasis Rubra Pilaris | 17 | 9/8 | 4 Israeli families | 41 | ||||||
2012 | DSAP | Disseminated Superficial Actinic Porokeratosis | >45 | 21/16/ND | 20 Chinese families, | 48.49 | Dominant | MVK | Mevalonate Kinase | 12q24 | C.604G>A |
p.Gly202Arg | |||||||||||
6 Chinese cases | |||||||||||
2010 | ALDD (JMP, NNS, CANDLE) | Autoinflammation, lipodystrophy, and dermatosis syndrome | 40 | 26/14 | 22 Japanese families | 53,57 | Recessive | PSMB8 | Proteasome Subunit, | 6p21.32 | c.224C>T, p.Thr75Met |
1 Portuguese family | 56 | Beta-Type, 8 | c.602G>T, | ||||||||
1 Mexican family | 56 | p.Gly201Val | |||||||||
3 Hispanic cases | 54 | ||||||||||
3 Spanish cases | 54 | ||||||||||
2 American cases | 54 | ||||||||||
1 Japanese case | 53 | ||||||||||
1 Israeli case | 54 | ||||||||||
1 Italian case | 9 | ||||||||||
2012 | APLAID | Autoinflammation, Antibody deficiency, and Immune Dysregulation syndrome | 2 | 1/1 | 1 family of unknown origin | 14 | Dominant | PLCG2 | Phospholipase C, gamma 2 | 16q23.3 | ND |
2012 | NA | Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis | 3 | 1/2 | 1 French family | 15 | Recessive | RBCK1 | RANBP-Type and C3HC4-Type Zinc Finger-Containing 1 | 20p13 | ND |
1 Italian case |